NIFTY 50▲24,846.25
440.15 (1.80%)
SENSEX▲81,385.85
1346.05 (1.68%)
NIFTY BANK▲51,320.75
432.00 (0.85%)
INDIAN RAILWAY FINANCE CORP▼183.55
-0.01 (-0.01%)
TATA MOTORS▲1,119.00
28.05 (2.57%)
TATA STEEL▲162.50
5.11 (3.25%)
TATA POWER▲444.80
21.45 (5.07%)
SUZLON ENERGY▲61.60
0.13 (0.21%)
RAIL VIKAS NIGAM▼551.50
-24.20 (-4.20%)
INDIAN RENEWABLE ENERGY▼257.99
-3.19 (-1.22%)
VODAFONE IDEA▲15.99
0.81 (5.34%)
RELIANCE INDUSTRIES▲3,021.05
36.25 (1.21%)
YES BANK▲25.02
0.40 (1.62%)
ADANI POWER▲713.50
18.30 (2.63%)
NHPC▲104.91
2.95 (2.89%)
STATE BANK OF INDIA▲863.10
14.60 (1.72%)
HDFC BANK▲1,619.90
3.30 (0.20%)
RELIANCE POWER▲29.86
0.17 (0.57%)
JIO FIN SERVICES LTD▲332.35
3.15 (0.96%)
ZOMATO▲224.54
5.23 (2.38%)
ADANI PORT & SEZ▲1,541.30
54.30 (3.65%)
BHARAT ELECTRONICS▲309.75
8.30 (2.75%)
INDIAN RAILWAY TOURISM CORP▲985.25
16.10 (1.66%)
INDIAN OIL CORP▼176.83
-0.02 (-0.01%)
RATTANINDIA POWER▲16.93
0.12 (0.71%)
MRF▲1,39,149.90
1559.80 (1.13%)
ADANI ENTERPRISES▲3,077.00
103.50 (3.48%)
JAIPRAKASH POWER VENTURES▲19.56
0.73 (3.88%)
![stock logo](https://assets.upstox.com/content/assets/images/logos/NSE_EQ|INE794A01010.png)
Neuland Lab Share Price
NEULANDLAB
₹8,375.00+₹0.35 (0.00%) TodayLast updated on 26 Jul, 2024 | 15:12 IST
₹8,315.95₹8,439.00
L
H
What’s in news?
Company overview
Financial performance
Market cap
| Open₹8,400.00 | Close₹8,374.65 |
Circuit range₹10,049.55 - ₹6,699.75 | Day range₹8,315.95 - ₹8,439.00 | Year range₹3,265.00 - ₹8,650.00 |
Volume7,461 | Avg. traded₹8,371.23 | Revenue (12m)₹1,559 Crs |
Neuland LabNeuland Laboratories Limited is an India-based company. The Company is engaged in manufacturing and selling of bulk drugs and caters to both domestic and international markets. The Company is an active pharmaceutical ingredient (API) manufacturing and development organization that caters to the pharmaceutical and biotech industry’s chemistry needs. It provides solutions across the full range of the pharmaceutical industry’s chemistry requirements, from the synthesis of library compounds to supplying New Chemical Entities (NCEs) and advanced intermediates at various stages in the clinical life cycle, as well as commercial launch. The Company has two business verticals: generic drug substances (GDS) and custom manufacturing solutions (CMS). Its key molecules include Mirtazapine, an anti-depressant and Levetiracetam, an anti-epileptic agent. The Company’s product portfolio includes over 100 APIs across 10 diverse therapeutic areas.
Neuland Lab Key indicators
52 week high₹8,650.00 | 52 week low₹3,265.00 | P/E ratio34.44 |
P/B ratio8.38 | ROE26.48% | ROCE33.62% |
Dividend yield0.17% | Debt/Equity ratio0.06 | EPS233.51 |
Learn more
Featured in
Investment checklist: (4/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
100%
Hold
0%
Sell
0%
This analysis is based on the reviews of 1 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin30.44% | Net profit margin19.22% |
ROE26.48% | ROA17.57% |
ROCE33.62% |
Learn more
Neuland Lab Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Thu, Jul 25 2024 | ₹8,370.00 | ₹8,374.65 | |
Wed, Jul 24 2024 | ₹8,053.95 | ₹8,370.05 | |
Tue, Jul 23 2024 | ₹8,010.65 | ₹8,054.05 | |
Mon, Jul 22 2024 | ₹8,051.00 | ₹8,010.60 | -1.47% |
Fri, Jul 19 2024 | ₹8,400.00 | ₹8,129.90 | -4.12% |
Thu, Jul 18 2024 | ₹8,444.20 | ₹8,479.45 | -0.03% |
Tue, Jul 16 2024 | ₹8,403.85 | ₹8,482.30 | |
Mon, Jul 15 2024 | ₹8,012.00 | ₹8,292.55 |
Events
Corporate actions
Dividend • ₹14/share
Ex date 12 Jul 2024
Dividend • ₹10/share
Ex date 11 Jul 2023
Dividend • ₹5/share
Ex date 14 Jul 2022
Learn more